Saul Priceman, Ph.D., Associate Professor Department of Hematology & Hematopoietic Cell Transplantation and Associate Director of Translational Sciences & Technologies in the T Cell Therapeutics Research Lab at City of Hope (IMAGE)

City of Hope

Saul Priceman, Ph.D., Associate Professor Department of Hematology & Hematopoietic Cell Transplantation and Associate Director of Translational Sciences & Technologies in the T Cell Therapeutics Research Lab at City of Hope

Caption

City of Hope’s Saul Priceman, Ph.D., is conducting research on chimeric antigen receptor (CAR)-engineered T cell therapy and has demonstrated in the laboratory and in preclinical models that the investigational cell therapy can work against ovarian cancer. The preclinical study was published in Nature Communications.

Credit

City of Hope

Usage Restrictions

Please do not re-use images

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.